This is a Validated Antibody Database (VAD) review about human DLC1, based on 2 published articles (read how Labome selects the articles), using DLC1 antibody in all methods. It is aimed to help Labome visitors find the most suited DLC1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
DLC1 synonym: ARHGAP7; STARD12; p122-RhoGAP; rho GTPase-activating protein 7; Rho-GTPase-activating protein 7; START domain-containing protein 12; StAR-related lipid transfer (START) domain containing 12; deleted in liver cancer 1 protein; deleted in liver cancer 1 variant 2; deleted in liver cancer variant 4; rho-type GTPase-activating protein 7

Santa Cruz Biotechnology
mouse monoclonal (C-12)
  • western blot; human; 1:1000; fig 3b
Santa Cruz Biotechnology DLC1 antibody (Santa Cruz, sc-271915) was used in western blot on human samples at 1:1000 (fig 3b). Oncol Lett (2017) ncbi
Invitrogen
rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:250; loading ...; fig 2a
  • western blot; human; loading ...; fig 4b
In order to examine methylation of the DLC1 isoform 1 alternative promoter in normal and meningioma FFPE samples, Invitrogen DLC1 antibody (Thermo Scientific, PA5-28443) was used in immunohistochemistry - paraffin section on human samples at 1:250 (fig 2a) and in western blot on human samples (fig 4b). J Neurooncol (2016) ncbi
Articles Reviewed
  1. Wu Z, Li Y, Zhang G. Downregulation of microRNA-301a inhibited proliferation, migration and invasion of non-small cell lung cancer by directly targeting DLC1. Oncol Lett. 2017;14:6017-6023 pubmed publisher
  2. Bujko M, Kober P, Rusetska N, WakuĊ‚a M, Goryca K, Grecka E, et al. Aberrant DNA methylation of alternative promoter of DLC1 isoform 1 in meningiomas. J Neurooncol. 2016;130:473-484 pubmed